1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > AIDS-Related Complex Global Clinical Trials Review, H2, 2014

AIDS-Related Complex Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “AIDS-Related Complex Global Clinical Trials Review, H2, 2014" provides data on the AIDS-Related Complex clinical trial scenario. This report provides elemental information and data relating to the clinical trials on AIDS-Related Complex. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating AIDS-Related Complex. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

AIDS-Related Complex Global Clinical Trials Review, H2, 2014
Table of Contents

Introduction 5
AIDS-Related Complex 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in North America 9
Top Countries Contributing to Clinical Trials in Middle East and Africa 10
Clinical Trials by G7 Countries: Proportion of AIDS-Related Complex to Infectious Disease Clinical Trials 11
Clinical Trials in G7 Countries by Trial Status 12
Clinical Trials by Phase 13
Clinical Trials by Trial Status 14
Clinical Trials by End Point Status 15
Unaccomplished Trials of AIDS-Related Complex 16
Subjects Recruited Over a Period of Time 17
Clinical Trials by Sponsor Type 18
Prominent Sponsors 19
Top Companies Participating in AIDS-Related Complex Therapeutics Clinical Trials 20
Clinical Trial Profiles 21
Clinical Trial Overview of Top Companies 21
F. Hoffmann-La Roche Ltd. 21
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 21
Bristol-Myers Squibb Company 23
Clinical Trial Overview of Bristol-Myers Squibb Company 23
Amgen Inc. 24
Clinical Trial Overview of Amgen Inc. 24
Pfizer Inc. 25
Clinical Trial Overview of Pfizer Inc. 25
GlaxoSmithKline plc 26
Clinical Trial Overview of GlaxoSmithKline plc 26
Johnson and Johnson 27
Clinical Trial Overview of Johnson and Johnson 27
Janssen Pharmaceuticals, Inc. 28
Clinical Trial Overview of Janssen Pharmaceuticals, Inc. 28
Jacobus Pharmaceutical Company 29
Clinical Trial Overview of Jacobus Pharmaceutical Company 29
Ewopharma AG 30
Clinical Trial Overview of Ewopharma AG 30
Bayer AG 31
Clinical Trial Overview of Bayer AG 31
Clinical Trial Overview of Top Institutes / Government 32
The National Institute of Allergy and Infectious Diseases 32
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 32
National Heart, Lung, and Blood Institute 34
Clinical Trial Overview of National Heart, Lung, and Blood Institute 34
St. Vincent Medical Center 35
Clinical Trial Overview of St. Vincent Medical Center 35
Institut Merieux 36
Clinical Trial Overview of Institut Merieux 36
University of Southern California 37
Clinical Trial Overview of University of Southern California 37
National Cancer Institute 38
Clinical Trial Overview of National Cancer Institute 38
University of California, San Francisco 39
Clinical Trial Overview of University of California, San Francisco 39
Five Key Clinical Profiles 40
Appendix 71
Abbreviations 71
Definitions 71
Research Methodology 72
Secondary Research 72
About GlobalData 73
Contact Us 73
Disclaimer 73
Source 73

List of Tables

AIDS-Related Complex Therapeutics, Global, Clinical Trials by Region, 2014* 6
AIDS-Related Complex Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
AIDS-Related Complex Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
AIDS-Related Complex Therapeutics Clinical Trials, North America, Top Countries, 2014* 9
AIDS-Related Complex Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 10
Proportion of AIDS-Related Complex to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 11
AIDS-Related Complex Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 12
AIDS-Related Complex Therapeutics, Global, Clinical Trials by Phase, 2014* 13
AIDS-Related Complex Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
AIDS-Related Complex Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
AIDS-Related Complex Therapeutics, Global, Terminated Clinical Trials, 2014* 16
AIDS-Related Complex Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 17
AIDS-Related Complex Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 18
AIDS-Related Complex Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 19
AIDS-Related Complex Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 20
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 21
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014* 23
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 24
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 25
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 26
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 27
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceuticals, Inc., 2014* 28
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by Jacobus Pharmaceutical Company, 2014* 29
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by Ewopharma AG, 2014* 30
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 31
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 32
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 34
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Vincent Medical Center, 2014* 35
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut Merieux, 2014* 36
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Southern California, 2014* 37
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 38
AIDS-Related Complex Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014* 39

List of Figures

AIDS-Related Complex Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
AIDS-Related Complex Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Proportion of AIDS-Related Complex to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 11
AIDS-Related Complex Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 12
AIDS-Related Complex Therapeutics, Global, Clinical Trials by Phase (%), 2014* 13
AIDS-Related Complex Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
AIDS-Related Complex Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
AIDS-Related Complex Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 17
AIDS-Related Complex Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 18
AIDS-Related Complex Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 19
AIDS-Related Complex Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 20
GlobalData Methodology 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025 Summary Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality ...

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Ulcerative Colitis: KOL Insight

Ulcerative Colitis: KOL Insight

  • $ 8085
  • Industry report
  • September 2016
  • by Firstword Pharma

Are UC biosimilars a real or perceived threat to branded drugs? Ulcerative colitis (UC) treatment is on the brink. Patents are ending on various branded drugs and clearing the way for an influx of biosimilars; ...

Hepatitis C: Kol Insight

September 2016 $ 8085

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.